title: Transparency or proper study valuation procedures missed?
authors.forename: Giampiero
authors.initials: G
authors.lastname: Favato
authors.forename: Gianluca
authors.initials: G
authors.lastname: Baio
authors.forename: Alessandro
authors.initials: A
authors.lastname: Capone
authors.forename: Andrea
authors.initials: A
authors.lastname: Marcellusi
authors.forename: Silvano
authors.initials: S
authors.lastname: Costa
authors.forename: Giorgia
authors.initials: G
authors.lastname: Garganese
authors.forename: Mauro
authors.initials: M
authors.lastname: Picardo
authors.forename: Mike
authors.initials: M
authors.lastname: Drummond
authors.forename: Bengt
authors.initials: B
authors.lastname: Jonsson
authors.forename: Giovanni
authors.initials: G
authors.lastname: Scambia
authors.forename: Peter
authors.initials: P
authors.lastname: Zweifel
authors.forename: Francesco S
authors.initials: FS
authors.lastname: Mennini
mesh_terms: D005260:Female; D006801:Humans; D030361:Papillomavirus Infections / Q000191:economics* / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000191:economics*; D014611:Vaccination / Q000191:economics*
chemical_list: D053918:Papillomavirus Vaccines